[go: up one dir, main page]

WO2000003687A3 - Potassium channel polypeptide and polynucleotide compositions - Google Patents

Potassium channel polypeptide and polynucleotide compositions Download PDF

Info

Publication number
WO2000003687A3
WO2000003687A3 PCT/US1999/016471 US9916471W WO0003687A3 WO 2000003687 A3 WO2000003687 A3 WO 2000003687A3 US 9916471 W US9916471 W US 9916471W WO 0003687 A3 WO0003687 A3 WO 0003687A3
Authority
WO
WIPO (PCT)
Prior art keywords
provides
potassium channel
potassium channels
channel polypeptide
screening assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/016471
Other languages
French (fr)
Other versions
WO2000003687A2 (en
Inventor
John R Forsayeth
Byron B Zhao
Raymond A Chavez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Elan Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharmaceuticals LLC filed Critical Elan Pharmaceuticals LLC
Priority to JP2000559822A priority Critical patent/JP2002520039A/en
Priority to EP99944996A priority patent/EP1097166A4/en
Priority to CA002337835A priority patent/CA2337835A1/en
Priority to AU57702/99A priority patent/AU5770299A/en
Publication of WO2000003687A2 publication Critical patent/WO2000003687A2/en
Publication of WO2000003687A3 publication Critical patent/WO2000003687A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides novel, isolated potassium channel subunits and polynucleotides which identify and encode such subunits. The invention also provides expression vectors and host cells comprising nucleic acid sequences encoding such potassium channels. The invention also provides antibodies directed to the potassium channels and methods of diagnosing and treating diseases associated with activity of such potassium channels. In addition, the invention provides screening assays employing the polypeptide, nucleotide, and antibody compositions, and agonist and antagonist compounds selected by such screening assays.
PCT/US1999/016471 1998-07-20 1999-07-20 Potassium channel polypeptide and polynucleotide compositions Ceased WO2000003687A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2000559822A JP2002520039A (en) 1998-07-20 1999-07-20 Compositions of potassium channel polypeptides and polynucleotides
EP99944996A EP1097166A4 (en) 1998-07-20 1999-07-20 Potassium channel polypeptide and polynucleotide compositions
CA002337835A CA2337835A1 (en) 1998-07-20 1999-07-20 Potassium channel polypeptide and polynucleotide compositions
AU57702/99A AU5770299A (en) 1998-07-20 1999-07-20 Potassium channel polypeptide and polynucleotide compositions

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9348698P 1998-07-20 1998-07-20
US9665598P 1998-08-13 1998-08-13
US60/096,655 1998-08-13
US60/093,486 1998-08-13

Publications (2)

Publication Number Publication Date
WO2000003687A2 WO2000003687A2 (en) 2000-01-27
WO2000003687A3 true WO2000003687A3 (en) 2000-04-20

Family

ID=26787595

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/016471 Ceased WO2000003687A2 (en) 1998-07-20 1999-07-20 Potassium channel polypeptide and polynucleotide compositions

Country Status (5)

Country Link
EP (1) EP1097166A4 (en)
JP (1) JP2002520039A (en)
AU (1) AU5770299A (en)
CA (1) CA2337835A1 (en)
WO (1) WO2000003687A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001819A1 (en) 1998-07-01 2000-01-13 Icagen, Incorporated Human elk, a voltage-gated potassium channel subunit
EP1297014A2 (en) * 2000-06-29 2003-04-02 Incyte Genomics, Inc. Transporters and ion channels
WO2005052576A1 (en) * 2003-11-27 2005-06-09 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 6 (kcnk6)
US9427441B2 (en) 2014-02-19 2016-08-30 Indiana University Research And Technology Corporation Targeting primary cilia to treat glaucoma
EP4367217A1 (en) * 2021-07-08 2024-05-15 Baylor College of Medicine Recombinant microorganism-based methods and compositions for treatment of disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599673A (en) * 1995-03-09 1997-02-04 University Of Utah Research Foundation Long QT syndrome genes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0930364A1 (en) * 1998-01-16 1999-07-21 Synthelabo TWIK-1 related two domains potassium channel
US6670149B1 (en) * 1999-03-01 2003-12-30 Millennium Pharmaceuticals, Inc. TWIK-5 potassium channel nucleic acids and uses therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599673A (en) * 1995-03-09 1997-02-04 University Of Utah Research Foundation Long QT syndrome genes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GELLENS M.E. ET AL: "Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel", PROC. NATL. ACAD. SCI., vol. 89, January 1992 (1992-01-01), pages 554 - 558, XP002925329 *
See also references of EP1097166A4 *

Also Published As

Publication number Publication date
AU5770299A (en) 2000-02-07
WO2000003687A2 (en) 2000-01-27
CA2337835A1 (en) 2000-01-27
JP2002520039A (en) 2002-07-09
EP1097166A4 (en) 2003-01-02
EP1097166A2 (en) 2001-05-09

Similar Documents

Publication Publication Date Title
WO2003004622A3 (en) Human secreted proteins
WO2001055310A8 (en) Nucleic acids, proteins, and antibodies
WO2001054472A8 (en) Nucleic acids, proteins, and antibodies
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
WO2001055306A8 (en) Nucleic acids, proteins, and antibodies
DK1131444T3 (en) Polypeptides with lysophospholipase activity and nucleic acid encoding them
WO2003000865A3 (en) Human secreted proteins
WO2001055326A3 (en) Nucleic acids, proteins, and antibodies
WO2000003687A3 (en) Potassium channel polypeptide and polynucleotide compositions
WO2003008626A3 (en) Novel human nucleic acids encoding a pantothenate kinase and methods of use
WO2001055168A8 (en) Nucleic acids, proteins and antibodies
WO2004042000A3 (en) 157 human secreted proteins
WO2001055440A8 (en) Nucleic acids, proteins, and antibodies
WO2002072763A3 (en) Nucleic acids, proteins, and antibodies
WO2001055167A8 (en) Nucleic acids, proteins, and antibodies
WO2001055305A8 (en) Nucleic acids, proteins, and antibodies
SE0101700D0 (en) Nucleotide sequences

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2337835

Country of ref document: CA

Ref country code: CA

Ref document number: 2337835

Kind code of ref document: A

Format of ref document f/p: F

Ref country code: JP

Ref document number: 2000 559822

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999944996

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999944996

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999944996

Country of ref document: EP